Priced for a smaller company: management is quietly telling investors the business has already outgrown what the numbers
The model's full reasoning — Q1 2017 call → NOWe need to determine if the call conveys that outsiders are currently underweighting something the company has already done, and management points to a concrete, already-completed or already-operating piece of the business whose contribution is still largely ahead of reported results. Let's analyze the transcript. Management discusses challenges in U.S. retail, but emphasizes that Guess? is different because it's global, with majority of revenues from outside U.S. They talk about Europe, Asia, etc. They mention three-year plan, investments, etc. Key points: They say "We are doing what we need to do, and are on the right path to becoming a stronger company and creating more shareholder value." They talk about transition period. They mention "the first six months of this year is a transition period for our three-year plan. We are now a little more than halfway through this transition. Investment made in the first half of this year will start generating revenue increases in the second half and continuing into the second and third year of our three-year plan." So they are saying investments made now will pay off later. But is that a recognition gap? They don't explicitly say outsiders are underweighting something already done. They talk about challenges, but they don't say "the market is not appreciating our already-built stores" or something like that. They mention "we have a lot of flexibility as roughly half our existing leases in the U.S. and Canada are either expiring or have kick out clauses in the next three years should we need to moderate our expansion plan or prune the store base based on productivity of existing stores." That's about flexibility, not about an already-built thing. They talk about Europe: "In Europe, we have a three-year revenue growth target of $300 million. This quarter our retail comps were up in the mid-teens with positive comps in almost all markets in the region. Our e-commerce business, although still relatively small continue to grow very rapidly. And in wholesale, the order book for fall winter 2016 finished up 3%. We are on track to open 45 stores in Europe this year. 10 of the 45 will be open in Russia through our newly formed joint venture partnership there which I am very excited about.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
PRPH · Q1 2023 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES The transcript shows management explicitly framing the current market view as mismatched with the company's actual position: "Anybody that's focused on us for earnings, you invested or are following the wrong company," "we're not an earnings story this year," and "focus less on revenues and earnings. This is a transition year." They repeatedly contrast this with the multi-billion-dollar assets already built and operating, whose contributions are still ramping or largely ahead. Concrete already-real items with meaningful payoff still ahead include: - The manufacturing facility (already at capacity, running nearly 100% YoY growth, with $25M revenue target for 2024 constrained only by capacity expansion this year; estimated $70M valuation next year plus $40M working capital and tens of millions in equipment). - Nebula Genomics (already generating >100% YoY revenue growth via direct-to-consumer sales; in-house whole-genome processing and B2B ramp expected in H2 202 3, particularly Q4, after validations complete in a couple of months).
KEY · Q3 2022 → YESThe question is: Does management convey that OUTSIDERS ARE CURRENTLY UNDERWEIGHTING SOMETHING THE COMPANY HAS ALREADY DONE — and does management answer that gap by pointing to at least one CONCRETE, A...YES Management repeatedly frames its interest-rate-risk positioning as something that “sets Key apart” and creates “unique and significant upside” that is not yet reflected in the market’s view of the company. Chris Gorman states that the $1.2 billion annualized benefit from re-pricing existing short-term Treasuries and swaps “ even in the event that rates remain at current levels” will arrive over the next two years, and Don Kimble confirms the same mechanics and timing. The $9 billion in short-term Treasuries and $26 billion in swaps are already on the balance sheet; the contribution is simply not yet in the reported results.
KIM · Q2 2018 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES Management explicitly frames the public-private pricing disconnect as a gap in how the company is valued versus its actual assets and execution. They point to the already-completed Toys "R" Us liquidation process (22 boxes resolved into OpCo and PropCo leases, with seven OpCo leases already signed and seven PropCo under 18-24 month resolution) as a concrete, already-real item whose rent contribution is still largely ahead in the reported results, with the 70-80 bps impact on occupancy and same-site NOI expected to be recaptured in Q3 and beyond.